ScienceOpen: research and publishing network

For Researchers

Search
Advanced search

238

views

    

0

recommends

4

shares

Record: found
Abstract: not found
Article: not found

What happened to personalized medicine?

Author(s): M Xie, J. Kijas, X. Xu, Y Dong, Y Jiang, Y Li, C. Bian, D Sweeney, A-P Zeng, S Zhao, Y. Zhang, X. Liu, W Nie, X Du, W Chen, J. Chen, S Yang, R Moore, G Tosser-Klopp, J. Wang, W. Zhang, W. Wang, B Sayre, B. Zhu, N. Xiao, J Womack, J. Liang, J Li, S Pan, Y. Hou, N Cockett, R. Zhao, Y Shen, G Zhang, B. Servin

Publication date: 2011-12-31

Journal: Nature biotechnology

Keywords: Biological Markers, Diagnosis, Disease, genetics, Drug Industry, Drug Therapy, Genotype, Humans, Individualized Medicine, Polymorphism, Genetic, United States, United States Food and Drug Administration

Read this article at

ScienceOpenPublisher PubMed

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

PubMed ID:: 22231070

DOI:: 10.1038/nbt.2096

ScienceOpen disciplines: Chemistry

Keywords: Biological Markers,Diagnosis,Disease,genetics,Drug Industry,Drug Therapy,Genotype,Humans,Individualized Medicine,Polymorphism, Genetic,United States,United States Food and Drug Administration

Data availability:

ScienceOpen disciplines: Chemistry

Keywords: Biological Markers, Diagnosis, Disease, genetics, Drug Industry, Drug Therapy, Genotype, Humans, Individualized Medicine, Polymorphism, Genetic, United States, United States Food and Drug Administration

Comments

Comment on this article